IBD

Immunology·MeSH: Inflammatory Bowel Diseases

11 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(3)

Phase 1(4)

Drug	Company
disc-0974	Disc Medicine, Inc. (IRON)
SER-301	Seres Therapeutics, Inc. (MCRB)
sl-425	Shattuck Labs, Inc. (STTK)
wtx-921	Werewolf Therapeutics, Inc. (HOWL)

Preclinical(2)

Drug	Company
kind-509	Kindred Biosciences, Inc. (KIN)
ser-603	Seres Therapeutics, Inc. (MCRB)

Unknown(2)

Drug	Company
CLS-001	Comera Life Sciences Holdings, Inc. (CMRA)
guselkumab	Innovation Pharmaceuticals Inc. (IPIX)

BioSniper tracks 11 drugs in development for IBD across 9 companies.

There are 1 clinical trial targeting IBD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.